Leszek Kotula

Institute For Basic Res In Dev Disabil

$3,165,897

Attributed

$3,165,897

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $378.4K · FY2005–22

$500K$375K$250K$125K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

Funding mix

By agency

NIH$3,165,897 · 3

By mechanism

R01$2,753,140 · 2

R21$412,757 · 1

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Prostate Cancer Therapy”

Charles A Coltman · Southwest Oncology Group$161,812,539
David Heimbrook · Leidos Biomedical Research, Inc.$108,390,837
Walter John Curran · Thomas Jefferson University$61,401,202
James J. Dignam · University Of Chicago$51,877,361
Norman Wolmark · Nsabp Foundation, Inc.$49,978,728
Laurence H Baker · University Of Michigan At Ann Arbor$43,597,690

Research focus

Prostate Cancer TherapySignal TransductionKnockout MiceProstatePten GeneSenescenceGene ExpressionGenetically Engineered MouseMalePathway InteractionsCessation Of LifeComplexPublishingBase1-Phosphatidylinositol 3-KinaseCell LineCancer EtiologyGenesAmericanCell Growth RegulationMalignant Neoplasm Of ProstateMalignant NeoplasmsCancer DiagnosisSmall Interfering Rna